ÂÜÀòÂÒÂ×

Travis Coy is currently Vice President, Transactions - Oncology and Diagnostics, Corporate Business Development at Eli Lilly and Company. Prior to this role, Mr. Coy was responsible for leading and managing business development transactions for Lilly’s cardiometabolic disease, drug delivery, and device efforts. He has had a variety of finance and business development experiences at Lilly, including positions as Finance Director of Lilly’s Oncology Business Unit, Director of Investor Relations, Director of Corporate Finance and Investment Banking, and other financial controllership roles. Travis’ business development experiences have encompassed responsibilities ranging from managing the strategic and economic analyses of transactions to leading contract negotiations to having financial leadership of alliances. Before transitioning to finance and business development, he was a chemist in Lilly’s research laboratories and a production manager for Milliken & Company.